295 related articles for article (PubMed ID: 16936530)
1. Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion.
Mourad JJ; Laville M
J Hypertens Suppl; 2006 Aug; 24(5):S10-6. PubMed ID: 16936530
[TBL] [Abstract][Full Text] [Related]
2. [The importance of microcirculation and tissue perfusion in hypertension].
Lévy BI
Curr Med Res Opin; 2005; 21 Suppl 5():S1-6. PubMed ID: 16197644
[TBL] [Abstract][Full Text] [Related]
3. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
Agabiti-Rosei E
Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
[TBL] [Abstract][Full Text] [Related]
4. [Role of microcirculation in hypertension].
Vicaut E
Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):636-42. PubMed ID: 12555470
[TBL] [Abstract][Full Text] [Related]
5. Importance of improving tissue perfusion during treatment of hypertension.
Lévy B
J Hypertens Suppl; 2006 Aug; 24(5):S6-9. PubMed ID: 16936534
[TBL] [Abstract][Full Text] [Related]
6. Evidence for benefits of perindopril in hypertension and its complications.
Laurent S
Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
[TBL] [Abstract][Full Text] [Related]
7. [Hypertension and microcirculation].
Boudier HA
Arch Mal Coeur Vaiss; 2002 Sep; 95 Spec No 6():17-22. PubMed ID: 12407782
[TBL] [Abstract][Full Text] [Related]
8. Effects of anti-hypertensive drugs on vessel rarefaction.
Battegay EJ; de Miguel LS; Petrimpol M; Humar R
Curr Opin Pharmacol; 2007 Apr; 7(2):151-7. PubMed ID: 17276727
[TBL] [Abstract][Full Text] [Related]
9. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
Motz W; Scheler S; Strauer BE
Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
[TBL] [Abstract][Full Text] [Related]
10. Microcirculation and arterial hypertension.
Vicaut E
Drugs; 1999; 58 Spec No 1():1-10. PubMed ID: 10526952
[TBL] [Abstract][Full Text] [Related]
11. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension.
Neglia D; Fommei E; Varela-Carver A; Mancini M; Ghione S; Lombardi M; Pisani P; Parker H; D'amati G; Donato L; Camici PG
J Hypertens; 2011 Feb; 29(2):364-72. PubMed ID: 21045728
[TBL] [Abstract][Full Text] [Related]
12. Microcirculation and arterial hypertension.
Vicaut E
Drugs; 1999; 59 Spec No():1-10. PubMed ID: 10548386
[TBL] [Abstract][Full Text] [Related]
13. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
Safar ME; Struijker-Boudier HA
Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
[TBL] [Abstract][Full Text] [Related]
14. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
[TBL] [Abstract][Full Text] [Related]
15. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
16. From macro- to microcirculation: benefits in hypertension and diabetes.
Agabiti-Rosei E
J Hypertens Suppl; 2008 Sep; 26(3):S15-9. PubMed ID: 19363848
[TBL] [Abstract][Full Text] [Related]
17. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor.
Levy BI; Duriez M; Samuel JL
Am J Hypertens; 2001 Jan; 14(1):7-13. PubMed ID: 11206683
[TBL] [Abstract][Full Text] [Related]
18. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
19. Arteriolar and capillary remodelling in hypertension.
Boudier HA
Drugs; 1999; 58 Spec No 1():37-40. PubMed ID: 10526957
[TBL] [Abstract][Full Text] [Related]
20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
